Title:
CIIP - UK Multisector - BioPlasticAccel - Accelerating biosynthesis of sustainable bioplastics for packaging, personal care, health and food
Agreement Number:
1034554
Agreement Value:
$494,208.00
Agreement Date:
Sep 1, 2025 - Aug 31, 2027
Description:
As part of the international consortium project "BioPlasticAccel", the Firm will develop yeast strains and fermentation methods for productino of key industrial chemicals, for use as renewable alternatives to petroleum-based plastics. Sustainable bioplastics may be used for packaging, personal care, and consumer goods.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2025-2026-Q2-1034554
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
850218033
Recipient Type:
For-profit organization
Recipient's Legal Name:
Renaissance BioScience Corp.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.